ribavirin has been researched along with epidermal growth factor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delcros, JG; Guguen-Guillouzo, C; Guillouzo, A; Ilyin, GP; Langouët, S; Rissel, M | 1 |
| Anatol, P; Danuta, P; Robert, F | 1 |
| Hörl, WH; Schmidt, A | 1 |
1 trial(s) available for ribavirin and epidermal growth factor
| Article | Year |
|---|---|
Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C.
Topics: Adult; Antiviral Agents; Biomarkers; Epidermal Growth Factor; Female; Growth Substances; Hepatitis C, Chronic; Hepatocyte Growth Factor; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Platelet-Derived Growth Factor; Prognosis; Recombinant Proteins; Ribavirin | 2005 |
2 other study(ies) available for ribavirin and epidermal growth factor
| Article | Year |
|---|---|
Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes.
Topics: Animals; Antimetabolites; Antiviral Agents; Cell Division; Cells, Cultured; Drug Antagonism; Epidermal Growth Factor; Hepatocyte Growth Factor; Humans; Liver; Male; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Ribavirin | 1998 |
Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
Topics: Adult; Animals; Antimicrobial Cationic Peptides; Antiviral Agents; Epidermal Growth Factor; Female; Hepacivirus; Hepatitis C, Chronic; Hepatocyte Growth Factor; Hepcidins; Humans; Interferon-alpha; Iron; Iron Overload; Liver Cirrhosis; Male; Middle Aged; Phlebotomy; Renal Insufficiency, Chronic; Ribavirin; Virus Replication | 2014 |